Ana Luzarraga Aznar

12PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Surgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 17, 2024
SENECA study: staging endometrial cancer based on molecular classification.

Enrique Chacon, Felix Boria, R Rajagopalan Lyer

|Aug 08, 2024
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy.

Violeta Romero, Martina Aida Angeles, Elena Rodríguez González

|Feb 20, 2024
Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer.

Ana Luzarraga Aznar, Vicente Bebia, Carlos López-Gil

|Sep 19, 2023
Endometrial adenocarcinoma recurring in the lung: impact of molecular profile and role of local therapies on prognosis.

Ana Luzarraga Aznar, Vicente Bebia, Carlos López-Gil

|Jun 10, 2021
Laparoscopic approach for symptomatic pelvic and para-aortic lymphoceles

Ana Luzarraga Aznar, Pia Español Lloret, Cristina Soler Moreno

Pageof 2